Literature DB >> 23828942

Somatic mutation, genomic variation, and neurological disease.

Annapurna Poduri1, Gilad D Evrony, Xuyu Cai, Christopher A Walsh.   

Abstract

Genetic mutations causing human disease are conventionally thought to be inherited through the germ line from one's parents and present in all somatic (body) cells, except for most cancer mutations, which arise somatically. Increasingly, somatic mutations are being identified in diseases other than cancer, including neurodevelopmental diseases. Somatic mutations can arise during the course of prenatal brain development and cause neurological disease-even when present at low levels of mosaicism, for example-resulting in brain malformations associated with epilepsy and intellectual disability. Novel, highly sensitive technologies will allow more accurate evaluation of somatic mutations in neurodevelopmental disorders and during normal brain development.

Entities:  

Mesh:

Year:  2013        PMID: 23828942      PMCID: PMC3909954          DOI: 10.1126/science.1237758

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  85 in total

1.  Coexistence of widespread clones and large radial clones in early embryonic ferret cortex.

Authors:  M L Ware; S F Tavazoie; C B Reid; C A Walsh
Journal:  Cereb Cortex       Date:  1999-09       Impact factor: 5.357

2.  Somatic mosaicism for Friedreich's ataxia GAA triplet repeat expansions in the central nervous system.

Authors:  L Montermini; S J Kish; S Jiralerspong; J B Lamarche; M Pandolfo
Journal:  Neurology       Date:  1997-08       Impact factor: 9.910

3.  Changes in cell-cycle kinetics during the development and evolution of primate neocortex.

Authors:  D R Kornack; P Rakic
Journal:  Proc Natl Acad Sci U S A       Date:  1998-02-03       Impact factor: 11.205

4.  Somatic mosaicism of the expanded CAG trinucleotide repeat in mRNAs for the responsible gene of Machado-Joseph disease (MJD), dentatorubral-pallidoluysian atrophy (DRPLA), and spinal and bulbar muscular atrophy (SBMA).

Authors:  Y Ito; F Tanaka; M Yamamoto; M Doyu; M Nagamatsu; S Riku; T Mitsuma; G Sobue
Journal:  Neurochem Res       Date:  1998-01       Impact factor: 3.996

5.  Doublecortin, a brain-specific gene mutated in human X-linked lissencephaly and double cortex syndrome, encodes a putative signaling protein.

Authors:  J G Gleeson; K M Allen; J W Fox; E D Lamperti; S Berkovic; I Scheffer; E C Cooper; W B Dobyns; S R Minnerath; M E Ross; C A Walsh
Journal:  Cell       Date:  1998-01-09       Impact factor: 41.582

6.  Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2.

Authors:  R E Amir; I B Van den Veyver; M Wan; C Q Tran; U Francke; H Y Zoghbi
Journal:  Nat Genet       Date:  1999-10       Impact factor: 38.330

Review 7.  Mosaic trisomy 22: a case presentation and literature review of trisomy 22 phenotypes.

Authors:  C A Crowe; S Schwartz; C J Black; V Jaswaney
Journal:  Am J Med Genet       Date:  1997-09-05

8.  Identification of the tuberous sclerosis gene TSC1 on chromosome 9q34.

Authors:  M van Slegtenhorst; R de Hoogt; C Hermans; M Nellist; B Janssen; S Verhoef; D Lindhout; A van den Ouweland; D Halley; J Young; M Burley; S Jeremiah; K Woodward; J Nahmias; M Fox; R Ekong; J Osborne; J Wolfe; S Povey; R G Snell; J P Cheadle; A C Jones; M Tachataki; D Ravine; J R Sampson; M P Reeve; P Richardson; F Wilmer; C Munro; T L Hawkins; T Sepp; J B Ali; S Ward; A J Green; J R Yates; J Kwiatkowska; E P Henske; M P Short; J H Haines; S Jozwiak; D J Kwiatkowski
Journal:  Science       Date:  1997-08-08       Impact factor: 47.728

9.  Clonal dispersion and evidence for asymmetric cell division in ferret cortex.

Authors:  C B Reid; S F Tavazoie; C A Walsh
Journal:  Development       Date:  1997-06       Impact factor: 6.868

10.  Constitutional aneuploidy in the normal human brain.

Authors:  Stevens K Rehen; Yun C Yung; Matthew P McCreight; Dhruv Kaushal; Amy H Yang; Beatriz S V Almeida; Marcy A Kingsbury; Kátia M S Cabral; Michael J McConnell; Brigitte Anliker; Marisa Fontanoz; Jerold Chun
Journal:  J Neurosci       Date:  2005-03-02       Impact factor: 6.167

View more
  228 in total

1.  More Than mTOR? Novel Roles for MEK-ERK1/2 and FLNA in Tuberous Sclerosis Complex.

Authors:  Chris G Dulla
Journal:  Epilepsy Curr       Date:  2015 Jul-Aug       Impact factor: 7.500

2.  DYRK1A overexpression enhances STAT activity and astrogliogenesis in a Down syndrome mouse model.

Authors:  Nobuhiro Kurabayashi; Minh Dang Nguyen; Kamon Sanada
Journal:  EMBO Rep       Date:  2015-09-15       Impact factor: 8.807

Review 3.  Genes, circuits, and precision therapies for autism and related neurodevelopmental disorders.

Authors:  Mustafa Sahin; Mriganka Sur
Journal:  Science       Date:  2015-10-15       Impact factor: 47.728

4.  Are Somatic Mutations in Cortical Development the One Bad Apple That Spoils the Bunch?

Authors:  Chris Dulla
Journal:  Epilepsy Curr       Date:  2015 Sep-Oct       Impact factor: 7.500

Review 5.  Genetic studies in intellectual disability and related disorders.

Authors:  Lisenka E L M Vissers; Christian Gilissen; Joris A Veltman
Journal:  Nat Rev Genet       Date:  2015-10-27       Impact factor: 53.242

Review 6.  Current Therapeutic Options in Sturge-Weber Syndrome.

Authors:  Anne Comi
Journal:  Semin Pediatr Neurol       Date:  2015-11-11       Impact factor: 1.636

Review 7.  Somatic mosaicism: on the road to cancer.

Authors:  Luis C Fernández; Miguel Torres; Francisco X Real
Journal:  Nat Rev Cancer       Date:  2015-12-18       Impact factor: 60.716

8.  Genetics of Epilepsy in Clinical Practice.

Authors:  Samuel F Berkovic
Journal:  Epilepsy Curr       Date:  2015 Jul-Aug       Impact factor: 7.500

Review 9.  Genetic Testing in Pediatric Epilepsy.

Authors:  Tristan T Sands; Hyunmi Choi
Journal:  Curr Neurol Neurosci Rep       Date:  2017-05       Impact factor: 5.081

10.  Exonic Mosaic Mutations Contribute Risk for Autism Spectrum Disorder.

Authors:  Deidre R Krupp; Rebecca A Barnard; Yannis Duffourd; Sara A Evans; Ryan M Mulqueen; Raphael Bernier; Jean-Baptiste Rivière; Eric Fombonne; Brian J O'Roak
Journal:  Am J Hum Genet       Date:  2017-08-31       Impact factor: 11.025

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.